arrow
A

An Tang

university of montreal
H指数:61
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Geographic and Sex Distribution of LI-RADS Research Globally: A Cross-Sectional Meta-Research Study

全球LI-RADS研究的地理和性别分布:一项横断面元研究

2026-04-120
PRE
Prospective Comparison of DWI-Derived Virtual MR Elastography and Conventional MR Elastography in Metabolic Dysfunction-Associated Steatotic Liver Disease and Healthy Volunteers

前瞻性比较DWI衍生的虚拟磁共振弹性成像与常规磁共振弹性成像在代谢功能障碍相关脂肪性肝病和健康志愿者中的差异

2025-11-011
OAAI
“A Responsible Framework for Applying Artificial Intelligence on Medical Images and Signals at the Point of Care: The PACS-AI Platform [Canadian Journal of Cardiology Volume 40, Issue 10, October 2024, Pages 1828-1840]”

“在医疗现场将人工智能应用于医学图像和信号的负责任框架: pacs-ai平台 [加拿大心脏病学杂志第40卷,第10期,2024年10月,1828-1840页]”

2025-10-210
OAAI
Part 2: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Risk Stratifying Patients With MASLD

第二部分:CAR代谢功能障碍相关脂肪性肝病工作组关于对MASLD患者进行风险分层的建议

2025-08-050
OA
Part 3: CAR Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Ultrasound Shear Wave Elastography and MR Elastography Program Implementation, Funding, and Quality Assurance

第三部分:与CAR功能障碍相关的脂肪性肝病工作组关于剪切波超声弹性成像和磁共振弹性成像项目实施、资金保障和质量保证的建议

2025-08-050
OA
Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI

第一部分:CAR代谢功能障碍相关脂肪性肝病工作组关于使用超声、CT或MRI检测和分级肝脂肪变性的指导声明

2025-08-050
OA
CT/MRI LI-RADS 2024 Update: Treatment Response Assessment (NOV, 10.1148/radiol.232408, 2024)

CT/MRI LI-RADS 2024年更新:治疗反应评估(NOV, 10.1148/radiol.232408, 2024)

RADIOLOGY
IF15.2
2025-02-010
PRE